Depressive characteristics of FSL rats: Involvement of central nicotinic receptors

Pharmacology Biochemistry and Behavior

Volumn 66, Issue 1, 2000, Pages 73-77

  Tizabi, Yousef ^a   Rezvani, Amir H ^b   Russell, Lemuel T ^a   Tyler, Khandra Y ^a   Overstreet, David H ^b  

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Animal model of depression; FSL rats; Mecamylamine; Nicotine; Nicotinic receptors; Swim test

Indexed keywords

CYTISINE; MECAMYLAMINE; NICOTINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CHRONICITY; CONTROLLED STUDY; DEPRESSION; IMMOBILIZATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; SWIMMING;

ALKALOIDS; ANIMALS; ANTIDEPRESSIVE AGENTS; AZOCINES; DEPRESSION; MALE; MECAMYLAMINE; NICOTINE; QUINOLIZINES; RATS; RECEPTORS, NICOTINIC;

ANIMALIA; NICOTIANA TABACUM;

EID: 0034080908     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(00)00236-7     Document Type: Article

References (33)

1. Albuquerque E.X., Pereira E.F.R., Castro N.G., Alkondon M., Reinhardt S., Schroder H., Maelicke A. Nicotinic receptor function in the mammalian central nervous system. NY Acad. Sci. 757:1995;48-69.
2. Barrantes G.E., Rogers A.T., Lindstrom J., Wonnacott S. Bungarotoxin binding sites in rat hippocampal and cortical cultures. initial characterisation, colocalisation with α-7 subunits and up-regulation by nicotine treatment Brain Res. 672:1995;228-236.
3. Breslau N., Peterson E.L., Schultz L.R., Chilcoat H.D., Andreski P. Major depression and stages of smoking - A longitudinal investigation. Arch. Gen. Psychiat. 55:1998;161-166.
4. Changeux J.P., Bertrand D., Corringer P.J., Dehaene S., Edelstein S., Lena C., Le Novere N., Marubio L., ;Picciotto M., Zoli M. Brain nicotinic receptors. structure and regulation, role in learning and reinforcement Brain Res. Rev. 26:1998;198-216.
5. Clarke P.B.S. Nicotinic receptors and cholinergic neurotransmission in the central nervous system. Ann. NY Acad. Sci. 757:1995;73-83.
6. 125I-alpha-bungarotoxin J. Neurosci. 5:1985;1307-1315.
7. Conti-Fine B.M., Maelicke A., Reinhardt-Maelicke S.R., Chiappinelli V., McLane K.E. Binding sites for neurotoxins and cholinergic ligands in peripheral and neuronal nicotinic receptors. Ann. NY Acad. Sci. 757:1995;133-153.
8. Covey L.S., Glassman A.H., Stetner F. Major depression following smoking cessation. Am. J. Psychiatry. 154:1997;263-265.
9. Djuric V.J., Dunn E., Overstreet D.H., Dragomir A., Steiner M. Antidepressant effects of ingested nicotine in female rats of Flinders resistant and sensitive lines. Physiol. Behav. 67:1999;533-537.
10. Flores C.M., Rogers S.W., Pabreza L.A., Wolfe B.B., Kellar K.J. A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment. Mol. Pharmacol. 41:1992;31-37.
11. Freedman R., Adler L.E., Bickford P., Byerley W., Coon H., Cullum M., Griffith J., Harris J.G., Leonard S., Miller C., Myles-Worsley M., Nagamoto H.T., Rose G.M., Waldo M. Schizophrenia and nicotinic receptors. Harv. Rev. Psychiatry. 2:1994;179-192.
12. Gilbert D.G. Depression, smoking, and nicotine. toward a bioinformational situation by trait model Drug Dev. Res. 38:1996;267-277.
13. Glassman A.H. Cigarette smoking. implications for psychiatric illness Am. J. Psychiatry. 150:1993;546-553.
14. Kendler K.S., Neal M.C., MacLean C.L., Heath A.C., Eaves L.J., Kessler R.C. Smoking and major depression. a causal analysis Arch. Gen. Psychiatry. 50:1993;36-43.
15. Lecca D., Auta J., Overstreet D.H., Guidotti A., Costa E., Javaid J.I. Differential sensitivity to nicotine-induced striatal dopamine release in Flinders sensitive and resistant lines. Soc. Neurosci. Abst. 25:1999;188.
16. Lu Y., Grady S., Marks M.J., Picciotto M., Changeux J.P., Collins A.C. Pharmacological characterization of nicotinic receptor-stimulated GABA release from mouse brain synaptosomes. J. Pharmacol. Exp. Ther. 287:1998;648-657.
17. Lucki I. The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behav. Pharmacol. 8:1997;523-532.
18. Lukas R.J., Bencherif M. Heterogeneity and regulation of nicotinic acetylcholine receptors. Int. Rev. Neurobiol. 34:1992;25-131.
19. Marks M.J., Grady S.R., Collins A.C. Downregulation of nicotinic receptor function after chronic nicotine infusion. J. Pharmacol. Exp. Ther. 266:1993;1268-1276.
20. Ochoa E.L.M., Li L., McNamee M.G. Desensitization of central cholinergic mechanisms and neuroadaptation to nicotine. Molec. Neurobiol. 4:1992;251-287.
21. Olale F., Gerzanich V., Kuryatov A., Wang F., Lindstrom J. Chronic nicotine exposure differentially affects the function of human α3, α4, and α7 neuronal nicotinic receptor subtypes. J. Pharmacol. Exp. Ther. 283:1997;675-683.
22. Overstreet D.H. The Flinders Sensitive Line rats. a genetic animal model of depression Neurosci. Biobehav. Rev. 17:1993;51-68.
23. Overstreet D.H., Pucilowski O., Rezvani A.H., Janowsky D.S. Administration of antidepressants, diazepam and psychomotor stimulants further confirms the utility of Flinders Sensitive Line rats as an animal model of depression. Psychopharmacology. 121:1995;27-37.
24. 3H]Cytisine binding to nicotinic cholinergic receptors in brain. Mol. Pharmacol. 39:1991;9-12.
25. Pucilowski O., Overstreet D.H. Effect of chronic antidepressant treatment on response to apomorphine in selectively bred rat strains. Brain Res. Bull. 32:1993;471-475.
26. Salin-Pascual R.J., de la Fuente J.R., Galicia-Polo I., Drucker-Colin R. Effects of transdermal nicotine on mood and sleep in nonsmoking major depressed patients. Psychopharmacology. 121:1995;476-479.
27. Salin-Pascual R.J., Drucker-Colin R. A novel effect of nicotine on mood and sleep in major depression. Neuro Report. 9:1998;57-60.
28. Schiller G.D., Pucilowski O., Wienicke C., Overstreet D.H. Immobility-reducing effects of antidepressants in a genetic animal model of depression. Brain Res. Bull. 28:1992;821-823.
29. Semba J., Mataki C., Yamada S., Nankai M., Toru M. Antidepressantlike effects of chronic nicotine on learned helplessness paradigms in rats. Biol. Psychiatry. 43:1998;389-391.
30. Tizabi Y., Overstreet D.H., Rezvani A.H., Louis V.A., Clark E. Jr., Janowsky D.S., Kling M.A. Antidepressant effects of nicotine in an animal model of depression. Psychopharmacology. 142:1999;193-199.
31. Vizi E.S., Lendvai B. Modulatory role of presynaptic nicotinic receptors in synaptic and non-synaptic chemical communication in the central nervous system. Brain Res. Rev. 30:1999;219-235.
32. Wonnacott S. Presynaptic nicotinic ACh receptors. Trends Neurosci. 20:1997;92-98.
33. Wonnacott S. The paradox of nicotinic acetylcholine receptor upregulation by nicotine. Trends Pharmacol. Sci. 11:1990;216-219.